Mr. Harland served as our Chief Financial Officer since March 2014 to December 2018. From June 2011 to March 2014, Mr. Harland served as Chief Financial Officer and Secretary of Wafergen Biosystems, Inc., a life sciences company focused on molecular biomarkers. From 2008 to 2010, Mr. Harland was Vice President of Finance and Administration and Assistant Secretary at Trinity Biosystems, Inc., a company focusing on oral delivery biopharmaceuticals. Mr. Harland began his career at Arthur Young & Company, is a certified public accountant (inactive), and holds FCA credentials. Mr. Harland received an M.A. in business studies and natural sciences from Cambridge University and an M.B.A. in taxation and finance at Golden Gate University.